News - Anti-Arthritics/Rheumatics, Krystexxa

Filter

Popular Filters

Majority of gout patients on uric acid lowering therapy fail to achieve control of serum urate levels report

10-06-2012

While rheumatologists and primary care physicians (PCPs) in the USA recognize the importance of tight…

allopurinolAnti-Arthritics/RheumaticsKrystexxaMarkets & MarketingNorth AmericaPharmaceuticalUloric

Allopurinol remains gout market leader but Uloric making inroads, study finds

18-04-2012

Most surveyed rheumatologists, nephrologists and primary care physicians cite increased use of Takeda's…

allopurinolAnti-Arthritics/RheumaticsGenito-urinaryKrystexxaMarkets & MarketingPharmaceuticalSavient PharmaceuticalsTakeda PharmaceuticalsUloric

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top